Methylation of the human papillomavirus-18 L1 gene: A biomarker of neoplastic progression?

Virology

Volumn 349, Issue 1, 2006, Pages 175-183

  Turan, Tolga ^a   Kalantari, Mina ^a   Calleja Macias, Itzel E ^a   Cubie, Heather A ^b   Cuschieri, Kate ^b   Villa, Luisa L ^c   Skomedal, Hanne ^d   Barrera Saldaña, Hugo A ^e   Bernard, Hans Ulrich ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^c LUDWIG INSTITUTE FOR CANCER RESEARCH   (Brazil)

^d Norchip Nuclisense Inc   (Norway)

^e UNIVERSIDAD AUTÓNOMA DE NUEVO LEÓN   (Mexico)

Author keywords

Cervical carcinoma; Epigenetic; Papillomavirus; Transcription regulation

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; BIOLOGICAL MARKER; CELL DNA; PROTEIN E6; TRANSCRIPTION FACTOR;

ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HELA CELL; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 18; METHYLATION; NONHUMAN; ONCOGENE; OVARY ADENOCARCINOMA; PRIORITY JOURNAL; PROMOTER REGION; SAMPLE; VIRUS GENE; VIRUS GENOME;

AZACITIDINE; CAPSID PROTEINS; CERVIX UTERI; DNA METHYLATION; DNA MODIFICATION METHYLASES; DNA, VIRAL; DNA-BINDING PROTEINS; ENZYME INHIBITORS; FEMALE; HELA CELLS; HUMANS; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; PROVIRUSES; REGULATORY ELEMENTS, TRANSCRIPTIONAL; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS; VIRAL PROTEINS;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS - 18; HUMAN PAPILLOMAVIRUS TYPE 18; PAPILLOMAVIRIDAE;

EID: 33646501446     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2005.12.033     Document Type: Article

References (42)

1. Ai W., Narahari J., and Roman A. Yin yang 1 negatively regulates the differentiation-specific E1 promoter of human papillomavirus type 6. J. Virol. 74 (2000) 5198-5205
2. Ambros P.F., and Karlic H.I. Chromosomal insertion of human papillomavirus 18 sequences in HeLa cells detected by nonisotopic in situ hybridization and reflection contrast microscopy. Hum. Genet. 77 (1987) 251-254
3. Andersson S., Rylander E., Larsson B., Strand A., Silfversvard C., and Wilander E. The role of human papillomavirus in cervical adenocarcinoma carcinogenesis. Eur. J. Cancer 37 (2001) 246-250
4. Badal V., Chuang L.S.H., Badal S., Tang E., Villa L.L., Wheeler C.M., Li B.F.L., and Bernard H.U. CpG methylation of human papillomavirus-16 DNA in cervical cancer cell lines and in clinical specimens: genomic hypomethylation correlates with carcinogenic progression. J. Virol. 77 (2003) 6227-6234
5. Badal S., Badal V., Calleja-Macias I.E., Kalantari M., Chuang L.S.H., Li B.F.L., and Bernard H.U. The human papillomavirus-18 genome is efficiently targeted by cellular DNA methylation. Virology 324 (2004) 483-492
6. Bauknecht T., Angel P., Royer H.D., and zur Hausen H. Identification of a negative regulatory domain in the human papillomavirus type 18 promoter: interaction with the transcriptional repressor YY1. EMBO J. 11 (1992) 4607-4617
7. Bernard H.U. Gene expression of genital human papillomaviruses and potential antiviral approaches. Antiviral Ther. 7 (2002) 219-237
8. Bird A.P. The essentials of DNA methylation. Cell 70 (1992) 5-8
9. Burk R.D., Terai M., Gravitt P., Brinton L.A., Kurman R.J., Barnes W.A.m., Greenberg M.D., Hadjimichael O.C., Fu L., McGowan L., Mortel R., Schwartz P.E., and Hildesheim A. Distribution of human papillomavirus types 16 and 18 variants in squamous cell carcinomas and adenocarcinomas of the cervix. Cancer Res. 63 (2003) 7215-7220
10. Burnett T.S., and Sleeman J.P. Uneven distribution of methylation sites within the human papillomavirus la genome: possible relevance to viral gene expression. Nucleic Acids Res. 12 (1984) 8847-8860
11. Calleja-Macias I.E., Kalantari M., Huh J., Ortiz-Lopez R., Rojas-Martines A., Gonzales-Guerrero J.F., Williamson A.L., Hagmar B., Wiley D.J., Villarreal L., Bernard H.U., and Barrera-Saldana H.A. High prevalence of specific variants of human papillomavirus-16, 18, 31, and 35 in a Mexican population. Virology 319 (2004) 315-323
12. Daniel B., Mukherjee G., Seshadri L., Vallikad E., and Krishna S. Changes in the physical state and expression of human papillomavirus type 16 in the progression of cervical intraepithelial neoplasia lesions analysed by PCR. J. Gen. Virol. 76 (1995) 2589-2593
13. de Villiers E.M., Fauquet C., Broker T.R., Bernard H.U., and zur Hausen H. Classification of papillomaviruses. Virology 324 (2004) 17-27
14. Doerfler W., Remus R., Muller K., Heller H., Hohlweg U., and Schubbert R. The fate of foreign DNA in mammalian cells and organisms. Dev. Biol. (Basel) 106 (2001) 89-97
15. Dyson N., Howley P., Munger K., and Harlow E. The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 243 (1989) 934-937
16. Fuks F. DNA methylation and histone modifications: teaming up to silence genes. Curr. Opin. Genet. Dev. 15 (2005) 490-495
17. Goll M.G., and Bestor T.H. Eukaryotic cytosine methyltransferases. Annu. Rev. Biochem. 74 (2005) 481-514
18. International Agency for Research on Cancer Monograph on the evaluation of carcinogenic risks to humans. Human Papillomaviruses vol. 64 (1995), IARC, Lyon
19. Kalantari M., Calleja-Macias I.E., Tewari D., Hagmar B., Barrera-Saldana H.A., Wiley D.J., and Bernard H.U. Conserved methylation patterns of human papillomavirus-16 DNA in asymptomatic infection and cervical neoplasia. J. Virol. 78 (2004) 12762-12772
20. Kim K., Garner-Hamrick P.A., Fisher C., Lee D., and Lambert P.F. Methylation patterns of papillomavirus DNA, its influence on E2 function, and implications in viral infection. J. Virol. 77 (2003) 12450-12459
21. Lazo P.A., DiPaolo J.A., and Popescu N.C. Amplification of the integrated viral transforming genes of human papillomavirus 18 and its 5′-flanking cellular sequence located near the myc protooncogene in HeLa cells. Cancer Res. 49 (1989) 4305-4310
22. Mincheva A., Gissmann L., and zur Hausen H. Chromosomal integration sites of human papillomavirus DNA in three cervical cancer cell lines mapped by in situ hybridization. Med. Microbiol. Immunol. (Berl.) 176 (1987) 245-256
23. Munoz N., Bosch F.X., de Sanjosé S., Herrero R., Castellsagué X., Shah K.V., Snijders P.J.F., and Meijer C.J.L.M. Epidemiological classification of human papillomavirus types associated with cervical cancer. N. Engl. J. Med. 348 (2003) 518-527
24. Myers, G., Bernard, H.U., Delius, H., Favre, M., Iconogle, J, van Ranst, M., Wheeler, C. (Eds.), 1994. Human papillomaviruses. Compendium. pp. 1-C-4-1-A-7. Los Alamos National Laboratory, Los Alamos, New Mexico, USA.
25. O'Connor M.J., Tan S.H., Tan C.H., and Bernard H.U. YY1 represses human papillomavirus type 16 transcription by quenching AP-1 activity. J. Virol. 70 (1996) 6529-6539
26. O'Connor M.J., Stünkel W., Koh C.H., Zimmermann H., and Bernard H.U. The differentiation-specific factor CDP/Cut represses transcription and replication of human papillomaviruses. J. Virol. 74 (2000) 401-410
27. Pattison S., Skalnik D.G., and Roman A. CCAAT displacement protein, a regulator of differentiation-specific gene expression, binds a negative regulatory element within the 5′ end of the human papillomavirus type 6 long control region. J. Virol. 71 (1997) 2013-2022
28. Popescu N.C., DiPaolo J.A., and Amsbaugh S.C. Integration sites of human papillomavirus 18 DNA sequences on HeLa cell chromosomes. Cytogenet. Cell. Genet. 44 (1987) 58-62
29. Romanczuk H., Villa L., Schlegel R., and Howley P. The viral transcriptional regulatory region upstream of the E6 and E7 genes is a major determinant of the differential immortalization activities of human papillomavirus types 16 and 18. J. Virol. 65 (1991) 2739-2744
30. Rosl F., Arab A., Klevenz B., and zur Hausen H. The effect of DNA methylation on gene regulation of human papillomaviruses. J. Gen.Virol. 74 (1993) 791-801
31. Schlegel R., Phelps W., Zhang Y., and Barbosa M. Quantitative keratinocyte assay detects two biological activities of human papillomavirus DNA and identifies viral types associated with cervical carcinoma. EMBO J. 7 (1988) 3181-3187
32. Schwartz S.M., Daling J., Shera K.A., Madeleine M.M., McKnight B., Galloway D.A., Porter P.L., and McDougall J.K. Human papillomavirus and prognosis of invasive cervical cancer: a population-based study. J. Clin. Oncol. 19 (2001) 1906-1915
33. Schwarz E., Freese U.K., Gissmann L., Mayer W., Roggenbuck B., Stremlau A., and zur Hausen H. Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature 314 (1985) 111-114
34. Stünkel W., and Bernard H.U. The chromatin structure of the long control region of human papillomavirus type 16 represses viral oncoprotein expression. J. Virol. 73 (1999) 1918-1930
35. Sugawara K., Fujinaga K., Yamashita T., and Ito Y. Integration and methylation of shope papilloma virus DNA in the transplantable Vx2 and Vx7 rabbit carcinomas. Virology 131 (1983) 88-99
36. Van Tine B.A., Kappes J.C., Banerjee N.S., Knops J., Lai L., Steenbergen R.D., Meijer C.L., Snijders P.J., Chatis P., Broker T.R., Moen Jr. P.T., and Chow L.T. Clonal selection for transcriptionally active viral oncogenes during progression to cancer. J. Virol. 78 (2004) 11172-11186
37. Velicescu M., Weisenberger D.J., Gonzales F.A., Tsai Y.C., Nguyen C.T., and Jones P.A. Cell division is required for de novo methylation of CpG islands in bladder cancer cells. Cancer Res. 62 (2002) 2378-2384
38. Villa L., and Schlegel R. Differences in transformation activity between HPV-18 and HPV-16 map to the viral LCR-E6-E7 region. Virology 181 (1991) 374-377
39. Werness B., Levine A., and Howley P. Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 248 (1990) 76-79
40. Wettstein F.O., and Stevens J.G. Shope papilloma virus DNA is extensively methylated in non-virus-producing neoplasms. Virology 126 (1983) 493-504
41. Wiley D.J., Huh J., Chang C., Kalantari M., Rao J.Y., Goetz M., Msongsong E., Poulter M., and Bernard H.U. Methylation of human papillomavirus DNA in samples of HIV-1 infected men screened for anal cancer. J. Acquired Immune Defic. Syndr. 39 (2005) 143-151
42. Zhao W., Noya F., Chen W.Y., Townes T.M., Chow L.T., and Broker T. Trichostatin A up-regulates human papillomavirus type 11 upstream regulatory region-E6 promoter activity in undifferentiated primary human keratinocytes. J. Virol. 73 (1999) 5026-5033